Safety, Tolerability, and Pharmacokinetics of Single and Repeat Doses of Nemiralisib Administered via the Ellipta Dry Powder Inhaler to Healthy Subjects
- Resource Type
- Short Communication
- Source
- In
Clinical Therapeutics August 2018 40(8):1410-1417 - Subject
- Language
- ISSN
- 0149-2918